Comparative Pharmacology
Head-to-head clinical analysis: MAGNESIUM SULFATE versus POTASSIUM CHLORIDE 0 3 IN DEXTROSE 5 AND SODIUM CHLORIDE 0 9 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MAGNESIUM SULFATE versus POTASSIUM CHLORIDE 0 3 IN DEXTROSE 5 AND SODIUM CHLORIDE 0 9 IN PLASTIC CONTAINER.
MAGNESIUM SULFATE vs POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Magnesium sulfate acts as a physiological calcium channel blocker. It inhibits calcium influx into presynaptic nerve terminals, reducing acetylcholine release at the neuromuscular junction and decreasing muscle contraction. It also antagonizes NMDA receptors and stabilizes neuronal membranes.
Potassium chloride (KCl) replaces potassium ions lost from the body and is essential for nerve conduction, muscle contraction, and maintenance of intracellular tonicity. Dextrose provides caloric support, and sodium chloride restores sodium and chloride deficits.
IV: Loading dose 4-6 g over 20-30 minutes, followed by maintenance infusion 1-2 g/hour for seizure prophylaxis in severe preeclampsia/eclampsia. IM: 4-8 g deep IM initially, then 4 g every 4 hours as needed.
Intravenous infusion; adult: 1000-2000 mL/day (providing 3 g NaCl, 50 g dextrose, and 30 mEq K+ per 1000 mL) at a rate determined by fluid and electrolyte needs, typically 0.5-1 mEq/kg/hr potassium; not to exceed 10 mEq/hr potassium without continuous cardiac monitoring.
None Documented
None Documented
Clinical Note
moderateMagnesium sulfate + Gatifloxacin
"The serum concentration of Gatifloxacin can be decreased when it is combined with Magnesium sulfate."
Clinical Note
moderateMagnesium sulfate + Rosoxacin
"The serum concentration of Rosoxacin can be decreased when it is combined with Magnesium sulfate."
Clinical Note
moderateMagnesium sulfate + Levofloxacin
"The serum concentration of Levofloxacin can be decreased when it is combined with Magnesium sulfate."
Clinical Note
moderateTerminal elimination half-life approximately 4-6 hours in patients with normal renal function; prolonged to 12-24 hours or more in renal impairment, necessitating dose adjustment
Potassium chloride: not applicable as a single half-life; plasma potassium is tightly regulated. Sodium chloride: no defined half-life; sodium and chloride are distributed and excreted according to homeostasis. Dextrose: rapid, with a half-life of 15-30 minutes for glucose in normal individuals.
Primarily renal (90-95% as unchanged drug); minor biliary/fecal (<5%)
Potassium chloride: primarily renal (90% excreted in urine, with minimal fecal loss). Sodium chloride: renal excretion accounts for >95% of eliminated sodium and chloride. Dextrose: completely metabolized to CO2 and water; no significant renal excretion.
Category C
Category A/B
Electrolyte
Electrolyte
Magnesium sulfate + Trovafloxacin
"The serum concentration of Trovafloxacin can be decreased when it is combined with Magnesium sulfate."